Efficacy and Safety of Harvoni (Ledipasvir/Sofosbuvir) in HCV Treatment in a Community Setting

被引：0
|
作者：
Abdullah, Khalid [1 ]
Dawood, Hasan [1 ]
Ortiz, Herman [1 ]
Zela, Scott [1 ]
Egwim, Chukwuma [1 ]
Ankoma-Sey, Victor [1 ]
机构：
[1] Liver Associates Texas PA, Houston, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-01012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1011
引用
收藏
页码：S564 / S565
页数：2
相关论文
共 50 条
  • [1] Effectiveness of Sofosbuvir/Ledipasvir HCV Treatment Regimens in a Community Setting
    Cheetham, T. Craig
    Liang, Anna Shuhua
    Bider-Canfield, Zoe
    Tartof, Sara Y.
    HEPATOLOGY, 2016, 64 : 966A - 966A
  • [2] Safety and Efficacy of Ledipasvir and Sofosbuvir for Hepatitis C in a Community Setting
    Thukral, Chandrashekhar
    Vicari, Joseph J.
    Bernsten, Andrew
    Geissler, Kathy
    Popejoy, Sara
    GASTROENTEROLOGY, 2016, 150 (04) : S1105 - S1105
  • [3] Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)
    Menon, Lalitha L.
    Chin, Beatrice
    Khattak, Muhammad A.
    INTERNAL MEDICINE JOURNAL, 2018, 48 (12) : 1542 - 1543
  • [4] Harvoni (Ledipasvir With Sofosbuvir)-Induced Renal Injury
    Wanchoo, Rimda
    Thakkar, Jyotsana
    Schwartz, Daniel
    Jhaveri, Kenar D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (01): : 148 - +
  • [5] A Combination of Ledipasvir and Sofosbuvir (Harvoni) for Hepatitis C
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 111 - 112
  • [6] The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease
    Simon, Tracey G.
    Kim, Arthur Y.
    Stamm, Luisa M.
    Liu, Lin
    Mo, Hongmei
    Doehle, Brian
    Pang, Phillip S.
    Brainard, Diana M.
    McHutchison, John G.
    Gustafson, Jenna
    Lauer, Georg M.
    Chung, Raymond T.
    ANTIVIRAL THERAPY, 2016, 21 (03) : 185 - 194
  • [7] Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
    Liu, Chun-Jen
    Chuang, Wan-Long
    Sheen, I-Shyan
    Wang, Horng-Yuan
    Chen, Chi-Yi
    Tseng, Kuo-Chih
    Chang, Ting-Tsung
    Massetto, Benedetta
    Yang, Jenny C.
    Yun, Chohee
    Knox, Steven J.
    Osinusi, Anu
    Camus, Gregory
    Jiang, Deyuan
    Brainard, Diana M.
    McHutchison, John G.
    Hu, Tsung-Hui
    Hsu, You-Chun
    Lo, Gin-Ho
    Chu, Chi-Jen
    Chen, Jyh-Jou
    Peng, Cheng-Yuan
    Chien, Ron-Nan
    Chen, Pei-Jer
    GASTROENTEROLOGY, 2018, 154 (04) : 989 - 997
  • [8] Efficacy and safety of ledipasvir/sofosbuvir therapy in HCV genotype 1 Korean patients
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 194 - 194
  • [9] Post Ledipasvir/sofosbuvir (Harvoni) Treatment: Is Hepatitis C Recurrence Around the Corner?
    Razjouyan, Hadie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1357 - S1358
  • [10] Efficacy and safety of sofosbuvir and ledipasvir combination therapy
    Nishibatake, Mizuki
    Minami, Tatsuya
    Tateishi, Ryosuke
    Fujinaga, Hidetaka
    Tanaka, Yasuo
    Otsuka, Motoyuki
    Kato, Naoya
    Yotsuyanagi, Hiroshi
    Koike, Kazuhiko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 378 - 378
12345